Blog Header

In: drug discovery

19 Jun, 2020Black Lives Matter in the Life Science Industry


Over the past weeks, Scientist.com has been working hard to listen, learn and implement short-term and long-term changes regarding diversity within our company…

Read More

31 Mar, 2020CUT&RUN – A Modern Application for Epigenomic Research


Guest blog written by antibodies-online.com CUT&RUN (Cleavage Under Targets and Release Using Nuclease) is a novel method to map genomic protein binding sites…

Read More

26 Feb, 2020The Benefits of Doing Research Down Under


Nicola Watkinson, General Manager of the Americas for the Australian Trade and Investment Commission (Austrade) explains the upside of conducting research Down Under….

Read More

19 Jun, 2019The Effects of Sex Bias in Preclinical Research and How it Can Be Changed


Upsetting the status quo is never easy, especially when it comes to scientific research. Just ask AstraZeneca duo Natasha A. Karp, Associate Principal Scientist/ Biostatistician and Neil Reavey, Associate Director, Research Assurance, who explore ways of overcoming the issue of sex bias in a paper entitled, “Sex Bias in Preclinical Research and Exploration of How to Change the Status Quo.”

Read More

12 Feb, 2019Regulatory Trends in Health Economics Outcomes Research (HEOR) & Real World Evidence (RWE)


As a relatively new means of conducting research in the life sciences, RWE, or real-world evidence, is data that comes from “real world settings” such as a clinical practice. Studies driven by real world evidence, or real-world data (RWD), can utilize data from medical records or claims databases, be conducted prospectively in observational studies or adhere to a mixed, hybrid-design approach.

Read More